Clinical Trial Update: Efficacy and Safety of Octreotide (MYCAPSSA™ [Formerly Octreolin™]) for Acromegaly [Phase 3]

View source ↗

Summary

Phase 3 trial results evaluate the efficacy and safety of MYCAPSSA (octreotide) for treating acromegaly. The study completed with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acromegaly

Drugs mentioned

• MYCAPSSA (Octreotide) (Octreotide)

Snippet

Sponsor: Chiasma, Inc. | Conditions: Acromegaly | Phase 3 | Status: COMPLETED | Results posted: 2015-12-01